AI assistant
GILEAD SCIENCES, INC. — Director's Dealing 2015
Aug 4, 2015
29828_dirs_2015-08-04_c4631402-6cf7-4baf-ab03-980e98eea8fe.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2015-08-03
Reporting Person: Alton Gregg H (EVP, Corp & Med Affairs)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-08-03 | Common Stock | M | 15000 | $23.755 | Acquired | 154422 | Direct |
| 2015-08-03 | Common Stock | S | 12206 | $118.9286 | Disposed | 142216 | Direct |
| 2015-08-03 | Common Stock | S | 4794 | $119.5719 | Disposed | 137422 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-08-03 | Non-Qualified Stock Option (right to buy) | $23.755 | M | 15000 | Disposed | 2020-01-28 | Common Stock (15000) | Direct |
Footnotes
F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
F2: The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.
F3: Sale prices reported for the transactions reported here range from $118.33 to $119.29. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
F4: Sale prices reported for the transactions reported here range from $119.335 to $120.05. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.